Skip to main content
To the Editor: We find the point made by Drs. Kellner and Fink regarding efficacy related to ECT treatment technique with reference to our study important and clinically relevant.
When planning our study, the status regarding efficacy and side effects of ECT treatment technique was suggestive but not conclusive of bilateral electrode placement compared with high-dose unilateral electrode placement being more effective. Cognitive side effects related to ECT treatment, on the other hand, were understudied regardless of ECT treatment technique, but bilateral compared with unilateral electrode placement seemed to carry a higher risk for long-term cognitive side effects (1, 2). This was the reason for choosing the right unilateral electrode placement in our study.
The large-scale study by the Consortium for Research in Electroconvulsive Therapy (CORE) group (3) has since added further support to the notion that bilateral electrode placement may be more effective than unilateral electrode placement in terms of speed of decreasing depressive symptoms without being associated with more cognitive side effects. In line with this, Drs. Kellner and Fink argue that the higher mean number of ECT treatments in our study compared with that in the CORE study may represent the use of the less effective unilateral electrode placement. Although we cannot rule out such an effect, the difference in efficacy in terms of speed and remission between the two studies may have well been caused by the differences in patient population.
The final comment by Drs. Kellner and Fink that “in real-world clinical settings, the option to use the most potent ECT techniques is an important aspect of optimized, ethical care” gives an impression that this is a straightforward choice but does not take into account the increased risk for retrograde amnesia associated with bilateral electrode placement. We find that Allan Scott (4) balanced the evidence regarding efficacy and side effect when he commented in an editorial that “there is no ideal electrode placement,” but method has to be weighted against the clinical condition and cognitive risk profile.

References

1.
Lisanby SH, Maddox JH, Prudic J et al: The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch Gen Psychiatry 2000; 57:581–590
2.
Sackeim HA, Prudic J, Fuller R et al: The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology 2007; 32:244–254
3.
Kellner CH, Knapp R, Husain MM et al: Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry 2010; 196:226–234
4.
Scott AI: Electroconvulsive therapy, practice and evidence. Br J Psychiatry 2010; 196:171–172

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 295 - 296
PubMed: 25727543

History

Accepted: December 2014
Published online: 1 March 2015
Published in print: March 01, 2015

Authors

Details

Helle K. Schoeyen, M.D., Ph.D.
From the MoodNet Research Group and Division of Psychiatry, Stavanger University Hospital, Stavanger, Norway; the MoodNet Research Group and Division of Psychiatry, Haukeland University Hospital, Bergen, Norway; Faculty of Medicine and Dentistry, Clinical Institute, University of Bergen, Norway; NORMENT, KB Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Norway; Research Department, Stavanger University Hospital and Faculty of Science and Technology, University of Stavanger, Norway; the Østmarka Department of Psychiatry, St. Olav University Hospital of Trondheim and Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Ute Kessler, M.D., Ph.D.
From the MoodNet Research Group and Division of Psychiatry, Stavanger University Hospital, Stavanger, Norway; the MoodNet Research Group and Division of Psychiatry, Haukeland University Hospital, Bergen, Norway; Faculty of Medicine and Dentistry, Clinical Institute, University of Bergen, Norway; NORMENT, KB Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Norway; Research Department, Stavanger University Hospital and Faculty of Science and Technology, University of Stavanger, Norway; the Østmarka Department of Psychiatry, St. Olav University Hospital of Trondheim and Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Ole A. Andreassen, M.D., Ph.D.
From the MoodNet Research Group and Division of Psychiatry, Stavanger University Hospital, Stavanger, Norway; the MoodNet Research Group and Division of Psychiatry, Haukeland University Hospital, Bergen, Norway; Faculty of Medicine and Dentistry, Clinical Institute, University of Bergen, Norway; NORMENT, KB Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Norway; Research Department, Stavanger University Hospital and Faculty of Science and Technology, University of Stavanger, Norway; the Østmarka Department of Psychiatry, St. Olav University Hospital of Trondheim and Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Bjoern H. Auestad, Ph.D.
From the MoodNet Research Group and Division of Psychiatry, Stavanger University Hospital, Stavanger, Norway; the MoodNet Research Group and Division of Psychiatry, Haukeland University Hospital, Bergen, Norway; Faculty of Medicine and Dentistry, Clinical Institute, University of Bergen, Norway; NORMENT, KB Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Norway; Research Department, Stavanger University Hospital and Faculty of Science and Technology, University of Stavanger, Norway; the Østmarka Department of Psychiatry, St. Olav University Hospital of Trondheim and Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Per Bergsholm, M.D., Ph.D.
From the MoodNet Research Group and Division of Psychiatry, Stavanger University Hospital, Stavanger, Norway; the MoodNet Research Group and Division of Psychiatry, Haukeland University Hospital, Bergen, Norway; Faculty of Medicine and Dentistry, Clinical Institute, University of Bergen, Norway; NORMENT, KB Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Norway; Research Department, Stavanger University Hospital and Faculty of Science and Technology, University of Stavanger, Norway; the Østmarka Department of Psychiatry, St. Olav University Hospital of Trondheim and Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Ulrik F. Malt, M.D., Ph.D.
From the MoodNet Research Group and Division of Psychiatry, Stavanger University Hospital, Stavanger, Norway; the MoodNet Research Group and Division of Psychiatry, Haukeland University Hospital, Bergen, Norway; Faculty of Medicine and Dentistry, Clinical Institute, University of Bergen, Norway; NORMENT, KB Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Norway; Research Department, Stavanger University Hospital and Faculty of Science and Technology, University of Stavanger, Norway; the Østmarka Department of Psychiatry, St. Olav University Hospital of Trondheim and Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Gunnar Morken, M.D., Ph.D.
From the MoodNet Research Group and Division of Psychiatry, Stavanger University Hospital, Stavanger, Norway; the MoodNet Research Group and Division of Psychiatry, Haukeland University Hospital, Bergen, Norway; Faculty of Medicine and Dentistry, Clinical Institute, University of Bergen, Norway; NORMENT, KB Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Norway; Research Department, Stavanger University Hospital and Faculty of Science and Technology, University of Stavanger, Norway; the Østmarka Department of Psychiatry, St. Olav University Hospital of Trondheim and Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Ketil J Oedegaard, M.D., Ph.D.
From the MoodNet Research Group and Division of Psychiatry, Stavanger University Hospital, Stavanger, Norway; the MoodNet Research Group and Division of Psychiatry, Haukeland University Hospital, Bergen, Norway; Faculty of Medicine and Dentistry, Clinical Institute, University of Bergen, Norway; NORMENT, KB Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Norway; Research Department, Stavanger University Hospital and Faculty of Science and Technology, University of Stavanger, Norway; the Østmarka Department of Psychiatry, St. Olav University Hospital of Trondheim and Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Arne Vaaler, M.D., Ph.D.
From the MoodNet Research Group and Division of Psychiatry, Stavanger University Hospital, Stavanger, Norway; the MoodNet Research Group and Division of Psychiatry, Haukeland University Hospital, Bergen, Norway; Faculty of Medicine and Dentistry, Clinical Institute, University of Bergen, Norway; NORMENT, KB Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Norway; Research Department, Stavanger University Hospital and Faculty of Science and Technology, University of Stavanger, Norway; the Østmarka Department of Psychiatry, St. Olav University Hospital of Trondheim and Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

Funding Information

The authors’ disclosures accompany the original article.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share